Glenmark Pharmaceuticals Ltd reported 18% decline in consolidated net profit.
Glenmark Pharmaceuticals Ltd on Friday reported an 18 per cent decline in consolidated net profit at ₹173.13 crore in the first quarter ended June 30, 2023, impacted by higher expenses. Glenmark…